Ligand validation:6PF9

MTX: METHOTREXATE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6PF9_MTX_D_604	48%	18%	0.193	0.935	1.62	1.87	5	11	1	0	100%	1
6PF9_MTX_B_604	47%	19%	0.191	0.931	1.61	1.86	5	11	3	0	100%	1
6PF9_MTX_C_604	43%	19%	0.201	0.925	1.62	1.84	5	9	2	0	100%	1
6PF9_MTX_E_604	42%	19%	0.2	0.92	1.6	1.86	5	10	2	0	100%	1
6PF9_MTX_A_604	31%	19%	0.22	0.891	1.62	1.86	5	10	2	0	100%	1
6PFG_MTX_C_604	69%	19%	0.151	0.965	1.6	1.85	5	9	3	0	100%	1
3HJ3_MTX_B_609	67%	13%	0.141	0.95	1.9	2.06	10	10	3	0	100%	1
6PFE_MTX_E_604	61%	16%	0.166	0.956	1.93	1.76	4	8	2	0	100%	1
2OIP_MTX_A_605	59%	22%	0.181	0.963	1.38	1.87	3	10	4	0	100%	1
6PFA_MTX_A_604	55%	19%	0.173	0.941	1.62	1.86	5	10	1	0	100%	1
1RA3_MTX_A_161	97%	9%	0.058	0.974	1.61	2.84	8	23	1	0	100%	1
1U72_MTX_A_188	97%	20%	0.065	0.979	1.13	2.23	2	16	2	0	100%	1
1RG7_MTX_A_161	94%	7%	0.071	0.968	1.88	2.93	9	17	1	0	100%	1
1DDR_MTX_B_200	93%	2%	0.077	0.971	2.29	4.49	7	20	0	1	100%	1
3IA4_MTX_A_164	91%	17%	0.077	0.962	1.84	1.8	3	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.